Home » Topics » BioWorld Science

BioWorld Science
RSS

Stretching taxes CRISPR's abilities

March 4, 2019

Typhus vaccination broadly alters immune response

March 4, 2019

To sleep, perchance to clean: Sleep-inducing protein plays role in immunity

March 4, 2019

FDA approves Herceptin Hylecta for HER2-positive breast cancer

March 1, 2019

Phase III FORWARD I trial of mirvetuximab soravtansine does not meet primary endpoint

March 1, 2019

Armed oncolytic adenovirus targets tumor stroma to enhance viral spread

March 1, 2019

Topivert Pharma initiates phase II/III study of TOP-1630 in dry eye syndrome

March 1, 2019

Minoryx receives Spanish clearance to begin phase II trial of MIN-102 in Friedreich's ataxia

March 1, 2019

Researchers find biomarkers associated with risk of GvHD

March 1, 2019

Apellis enters collaboration with SFJ Pharmaceuticals for APL-2 in hematologic indications

March 1, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...